Table 5.
Comorbidities and behavioural patterns of patients enrolled in our study
| Characteristics | Vaccinated, n = 437 | Non-vaccinated, N = 120 | p value |
|---|---|---|---|
| Arterial hypertension, n (%) | 139 (31.8) | 29 (24.2) | 0.144 |
| Coronary heart disease, n (%) | 27 (6.2) | 5 (4.2) | 0.510 |
| Congestive heart failure, n (%) | 5 (1.1) | 2 (1.7) | 0.645 |
| Diabetes mellitus, n (%) | 36 (8.2) | 3 (2.5) | 0.027 |
| Chronic kidney disease, n (%) | 31 (7.1) | 8 (6.7) | 1.000 |
| Chronic obstructive pulmonary disease, n (%) | 19 (4.3) | 0 (0.0) | 0.019 |
| Missed appointment (during last year), n (%) | 169 (38.7) | 54 (45.0) | 0.207 |
| Treatment discontinuation amid first COVID-19 wave, n (%) | 6/250 (2.4) | 2/73 (2.7) | 1.000 |
| Nocebo behaviour, n (%)a | 23/352 (6.5) | 18/65 (27.7) | 0.0001 |
| Negative vaccination behaviour, n (%)a | 30 (6.9) | 47 (39.2) | 0.0001 |
Comparison between vaccinated and unvaccinated patients
aFor definitions please see “Patients and methods”